Cargando…
Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts
Renal fibrosis is the final common pathway of chronic kidney disease (CKD), and no effective medication is available clinically for managing its progression. Metformin was initially developed as an anti-diabetic drug and recently gained attention for its potential in the treatment of other diseases....
Autores principales: | Shen, Yang, Miao, Naijun, Xu, Jinlan, Gan, Xinxin, Xu, Dan, Zhou, Li, Xue, Hong, Zhang, Wei, Lu, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783880/ https://www.ncbi.nlm.nih.gov/pubmed/26805826 http://dx.doi.org/10.3390/ijms17020146 |
Ejemplares similares
-
Metformin attenuates renal interstitial fibrosis through upregulation of Deptor in unilateral ureteral obstruction in rats
por: Wang, Yanxia, et al.
Publicado: (2020) -
FFNT25 ameliorates unilateral ureteral obstruction-induced renal fibrosis
por: Li, Wen, et al.
Publicado: (2019) -
Protective effects of quercetin and hyperoside on renal fibrosis in rats with unilateral ureteral obstruction
por: YAN, YANG, et al.
Publicado: (2014) -
L-Endoglin Overexpression Increases Renal Fibrosis after Unilateral Ureteral Obstruction
por: Oujo, Bárbara, et al.
Publicado: (2014) -
Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction
por: BABA, ITSUKO, et al.
Publicado: (2015)